C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2009
10/27/2009	US7608426 Nucleotide sequences coding for interleukin polypeptide for use as tool in tissue repair
10/27/2009	US7608422 Gene therapy; vaccines; inducing antibodies and/or cytotoxic or helper T lymphocytes
10/27/2009	US7608411 Prostaglandin receptor EP1
10/27/2009	US7608410 Method of improving T cell receptors
10/27/2009	US7608409 Screening assay using G-protein coupled receptor protein OT7T175
10/27/2009	US7608408 Methods of identifying compounds that inhibit Notch cleavage
10/27/2009	US7608401 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis
10/27/2009	US7608276 vaccines, immunogenic compositions; diagnostics, enzymatic studies and targets for antibiotics; for treating Staphylococcus aureus infection
10/27/2009	US7608273 glycoprotein cationic polypeptide as HIV vaccines; nontoxic
10/27/2009	US7608271 Modified human immunodeficiency virus anti-fusogenic GP41 peptides comprising a maleimide-containing group
10/27/2009	US7608269 Compositions and methods for treating cancer by modulating HER-2 and EGF receptors
10/27/2009	US7608268 Ferritin fusion proteins for use in vaccines and other applications
10/27/2009	US7608267 Fusion protein of two different cytokines, one capable of enhancing a nonspecific immune response, and the other capable of enhancing a specific immunity; fusion protein of Interleukin-2 (Il-2) and IL-7 for example; use in immunotherapy such as cancer vaccine
10/27/2009	US7608264 Monoclonal antibody or antibody fragment which binds a pleiotrophin-binding fragment of human Anaplastic Lymphoma Kinase (ALK) and inhibits a pleiotrophin-mediated activity; prevents pleiotrophin-mediated neoplastic or mitogenic activity
10/27/2009	US7608262 Such as antibodies; treating acute mycocardial infarction, deep vein thrombosis, stroke and thrombophlebitis
10/27/2009	US7608261 VEGF antagonist formulations suitable for intravitreal administration
10/27/2009	US7608256 Methods to increase transgene expression from bacterial-based delivery systems by co-expressing suppressors of the eukaryotic type I interferon response
10/27/2009	US7608255 Replication-competent anti-cancer vectors
10/27/2009	US7608243 RGD peptide sequence; labelled with fluorescein used as contrast agents in optical imaging in diagnosis of angiogenesis-related diseases; peptidic vector and the fluorescein dye are coupled; cyclic peptide forming disulife or monothioether bridge
10/27/2009	US7608242 Peptide-chelate conjugates
10/27/2009	CA2328904C Novel (poly)peptides which represent the epitopes of the human herpesvirus type 8
10/27/2009	CA2288184C Method for treating a lactic raw material containing gmp
10/27/2009	CA2162366C Conjugation-stabilized polypeptide compositions
10/27/2009	CA2148492C Bovine heat shock promoter and uses thereof
10/27/2009	CA2146145C Immunogenic meningococcal lps and outer membrane vesicles and vaccine therefrom
10/26/2009	WO2006111524A2 Il-21 variants
10/22/2009	WO2009129549A2 Babesia microti genomic clones containing novel antigens useful in the diagnosis of babesiosis
10/22/2009	WO2009129497A2 Methods and compositions for treating and identifying compounds to treat age-related macular degeneration
10/22/2009	WO2009129379A1 Methods for enhanced production of bone morphogenetic proteins
10/22/2009	WO2009129311A2 Somatostatin receptor 2 antagonists
10/22/2009	WO2009129263A1 Peptides promoting lipid efflux via abca1 and activating a lipoprotein lipase
10/22/2009	WO2009129250A2 Meal-time insulin analogues of enhanced stability
10/22/2009	WO2009129018A1 Analysis of amino acid copolymer compositions
10/22/2009	WO2009128949A2 Compositions of dengue viral proteins and methods of use
10/22/2009	WO2009128772A1 Stable amyloid beta monomers and oligomers
10/22/2009	WO2009128713A1 Egg protein hydrolysates
10/22/2009	WO2009128448A1 Novel protein capable of binding to hyaluronic acid, and method for measurement of hyaluronic acid using the same
10/22/2009	WO2009128077A1 Stable cell binding chimeric peptides
10/22/2009	WO2009127881A1 Anti-areg/hb-egf antibodies and treatment
10/22/2009	WO2009127826A1 Recombinant fsh including alpha 2,3- and alpha 2,6-sialylation
10/22/2009	WO2009127797A1 Agent and method for the reduction of parasitic flatworms
10/22/2009	WO2009127766A1 System for the expression of peptides on the bacterial surface
10/22/2009	WO2009127729A1 Polypeptides having ferulic acid esterase activity and polynucleotides encoding same
10/22/2009	WO2009127705A1 Novel therapeutical tools and methods for treating blindness
10/22/2009	WO2009127441A2 Transcription factors involved in drought stress in plants
10/22/2009	WO2009127249A1 Method for identifying compounds suitable for stimulation of stem cell production in skin
10/22/2009	WO2009127211A1 Methods and kits for determining spinal dysmyelination
10/22/2009	WO2009127154A1 A newly identified human rhinovirus of hrv-c and methods and kits for detecting hrv-cs
10/22/2009	WO2009127072A1 Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and related methods of preparation and use
10/22/2009	WO2009127060A1 Novel lipid formulations for nucleic acid delivery
10/22/2009	WO2009127050A1 Functional enhancement of yeast to minimize production of ethyl carbamate via modified transporter expression
10/22/2009	WO2009127046A1 Prostate specific membrane antigen antibodies and antigen binding fragments
10/22/2009	WO2009114831A3 Process to produce fibrillar proteins and method of treating using fibrillar proteins
10/22/2009	WO2009108774A3 Use of synthetic scaffolds for the production of biosynthetic pathway products
10/22/2009	WO2009106819A3 Biological materials and uses thereof
10/22/2009	WO2009105783A4 Cosmetic and dermatological formulations of mntf peptides
10/22/2009	WO2009105572A3 Antisense modulation of amyloid beta protein expression
10/22/2009	WO2009102357A3 Hiv-1 envelope glycoprotein oligomer and methods of use
10/22/2009	WO2009097017A3 Antibodies and fc fusion protein modifications with enhanced persistence or pharmacokinetic stability in vivo and methods of use thereof
10/22/2009	WO2009093251A3 Reovirus vaccine based on sigma c protein sequence
10/22/2009	WO2009092772A3 Plants having enhanced yield-related traits and a method for making the same
10/22/2009	WO2009088405A3 System and method utilizing the expression of tlk1b protein in normal human cells to protect against dna damage
10/22/2009	WO2009041832A9 Vaccines and vaccine components for inhibition of microbial cells
10/22/2009	WO2007125210A8 Use of multivalent synthetic ligands of surface nucleolin for treating cancer or inflammation
10/22/2009	WO2001000878A9 A novel vascular endothelial growth factor family member and uses thereof
10/22/2009	US20090265816 Isolated nucleic acid molecules from the genome of citrus leprosis virus and uses thereof
10/22/2009	US20090265815 Sequence-determined DNA fragments and corresponding polypeptides encoded therapy
10/22/2009	US20090265809 Modified Cry3A Toxins and Nucleic Acid Sequences Coding Therefor
10/22/2009	US20090265807 transcription factor polynucleotides; transgenic plants having increased soluble solids, lycopene, and improved plant volume or yield, increased anthocyanin in leaves, seedling vigor
10/22/2009	US20090265805 Glutamate receptors in nutrient sensing, metabolism, Growth and Development
10/22/2009	US20090265796 DNA segment that confers increased episomal stability, persistence or abundance of the isolated DNA molecule in a host cell; genetic engineering
10/22/2009	US20090265114 Influenza virus neuraminidase crystal structure and their use thereof
10/22/2009	US20090264634 Sequences characteristic of hypoxia-regulated gene transcription
10/22/2009	US20090264631 Immunoadsorption of anti-von willebrand factor cleaving protease antibodies
10/22/2009	US20090264627 Increasing half-life of immunoglobulin fusion via alteration of carboxy-terminal with cytokine protein; directed protein evolution; antitumor agents
10/22/2009	US20090264626 Stabilization of the collagen triple helix by o-methylation of hydroxyproline residues
10/22/2009	US20090264625 Method for recombinant microorganism expression and isolation of collagen-like polypeptides
10/22/2009	US20090264624 Human cytokine receptor
10/22/2009	US20090264623 Sodium channel protein type iii alpha-subunit splice variant
10/22/2009	US20090264622 Rhesus monkey Nur77
10/22/2009	US20090264618 Compounds With a Branched Linker
10/22/2009	US20090264455 Androgen Receptor Modulator Compounds and Methods
10/22/2009	US20090264381 Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer
10/22/2009	US20090264370 Polypeptides homologous to vegf and bmp1
10/22/2009	US20090264366 Transglutaminase Mediated Conjugation of Peptides
10/22/2009	US20090264365 Conformationally constrained parathyroid hormone (pth) analogs
10/22/2009	US20090264364 Genes implicated in the regulation of angiogenesis, pharmaceutical preparations containing them and their applications
10/22/2009	US20090264361 Identification of a family of secreted proteins in vascular endothelium
10/22/2009	US20090264360 Cloning and expression of gonadotropin-releasing hormone (GnRH) receptors
10/22/2009	US20090264359 Fplr-1 inhibitors for use in diseases involving amyloid-induced inflammatory events (flipr and flipr-like) and immunecomplex-mediated diseases
10/22/2009	US20090264356 Adenovirus 36 E4 orf 1 Gene and Protein and Their Uses
10/22/2009	US20090264354 Penumbra Nucleic Acid Molecules, Proteins and Uses Thereof
10/22/2009	US20090264353 Splice Switching Oligomers for TNF Superfamily Receptors and their Use in Treatment of Disease
10/22/2009	US20090264351 Antifungal polypeptides
10/22/2009	US20090264349 CD30 Ligand
10/22/2009	US20090264303 Polypeptides having a functional domain of interest and methods of identifying and using same
10/22/2009	US20090263897 Reishi f3 sub fraction polysaccharides and methods of using same
10/22/2009	US20090263883 Recombinant Parainfluenza Virus Expression Systems And Vaccines Comprising Heterologous Antigens Derived From Respiratory Syncytial Virus
10/22/2009	US20090263881 Alpha-Amylase Mutants
10/22/2009	US20090263864 Recombinant production of mixtures of antibodies

1 ... 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 ... 2916